Lung cancer is the third most common form of cancer in the U.S. and annually claims more lives than breast, prostate and colon cancer combined. Screening...
NeuroSense Therapeutics Ltd. announced it has entered into a securities purchase agreement with a single health-care focused institutional investor for the purchase and sale of 2,980,000...
Labcorp announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Mpox PCR Test Home Collection Kit to aid in...
PACS Group, Inc. announced the pricing of its upsized initial public offering of 21,428,572 shares of its common stock being sold by the Company at a...
16 Bit Inc. announced that the U.S. Food and Drug Administration (FDA) has granted a De Novo marketing authorization for Rho™, an AI-enabled software device aimed...
Medical Properties Trust, Inc. announced that it completed its previously announced sale of five facilities in California and New Jersey to Prime Healthcare for aggregate consideration...
The U.S. District Court for the Western District of Pennsylvania entered a consent decree of permanent injunction against Philips RS North America LLC (“Philips Respironics”), Respironics...
Onkos Surgical announced that the U.S. Food & Drug Administration (FDA) has granted the company a De Novo approval for its novel antibacterial coated implants. Bacterial...
Ascend Advanced Therapies has acquired the CMC team and site in Alachua, Florida from Beacon Therapeutics (Beacon). The transaction brings an operational good manufacturing practice (GMP)...
Illumina, Inc. announced that Joydeep Goswami has decided to leave Illumina. He will stay on in an advisory role through June 30 to support two new...
NeurAxis, Inc. announced results for the fourth quarter and fiscal year 2023 for the period ended December 31, 2023. Management commentary Brian Carrico, Chief Executive Officer...
Mainz Biomed N.V. announced financial results for the fiscal year ended December 31, 2023. “This past fiscal year represented an important period of progress for the...
MMI announced that its Symani® Surgical System is now commercially available in the United States. The U.S. Food and Drug Administration (FDA) granted De Novo Classification...
TransMedics Group, Inc. announced that on April 4, 2024, TransMedics granted non-qualified stock options to purchase an aggregate of 9,722 shares of its common stock and...
Spirair™ announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SeptAlign™ System. This comes on the heels of FDA...
Copyright © 2024 Medical Buyer